Evidence map›Paper›PMID 26193433›Full record

ArticleBiochimica et biophysica acta2015

Regulation of hepatic lipase activity by sphingomyelin in plasma lipoproteins.

Peng Yang, Papasani V Subbaiah

Abstract read
In one paragraph

Article in Biochimica et biophysica acta, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Potential role of hepatic lipase in the accretion of docosahexaenoic acid (DHA) by the brain.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Peng YangSection of Endocrinology and Metabolism, Department of Medicine, University of Illinois at Chicago, 1819 West Polk M/C 797, Chicago, United States; Jesse Brown VA Medical Center, Chicago, IL, United States.
Papasani V SubbaiahSection of Endocrinology and Metabolism, Department of Medicine, University of Illinois at Chicago, 1819 West Polk M/C 797, Chicago, United States; Jesse Brown VA Medical Center, Chicago, IL, United States. Electronic address: psubbaia@uic.edu.
University of Illinois Chicago · US

Funding

ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISMR01HL068585 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SUBBAIAH, PAPASANI V · 2002 to 2012
$3.3M
Purchase of AB Sciex QTRAP 5500 SystemS10OD010660 · OD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SUBBAIAH, PAPASANI V · 2012 to 2012
$440k
Molecular Form of Dietary DHA and its Bioavailability for the BrainR21AT008457 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SUBBAIAH, PAPASANI V · 2014 to 2015
$431k
Role of Sphingomyelin in Lipoprotein MetabolismR56HL068585 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SUBBAIAH, PAPASANI V · 2008 to 2008
$393k
Role of Membrane Modifications in the Bioactivities of Conjugated Linoleic AcidsI01BX001090 · VA · JESSE BROWN VA MEDICAL CENTER · PI SUBBAIAH, PAPASANI V · 2013 to 2016
–
BLRD VA I01 BX001090NCCIH NIH HHS AT008457NCCIH NIH HHS R21 AT008457NHLBI NIH HHS HL068585NHLBI NIH HHS R01 HL068585NHLBI NIH HHS R56 HL068585NIH HHS S10 OD010660NIH HHS S10OD010660
6 · The paper itself

Abstract

Hepatic lipase (HL) is an important enzyme in the clearance of triacylglycerol (TAG) from the circulation, and has been proposed to have pro-atherogenic as well as anti-atherogenic properties. It hydrolyzes both phospholipids and TAG of lipoproteins, and its activity is negatively correlated with HDL levels. Although it is known that HL acts preferentially on HDL lipids, the basis for this specificity is not known, since it does not require any specific apoprotein for activity. In this study, we tested the hypothesis that sphingomyelin (SM), whose concentration is much higher in VLDL and LDL compared to HDL, is an inhibitor of HL, and that this could explain the lipoprotein specificity of the enzyme. The results presented show that the depletion of SM from normal lipoproteins activated the HL roughly in proportion to their SM content. SM depletion stimulated the hydrolysis of both phosphatidylcholine (PC) and TAG, although the PC hydrolysis was stimulated more. In the native lipoproteins, HL showed specificity for PC species containing polyunsaturated fatty acids at sn-2 position, and produced more unsaturated lyso PC species. The enzyme also showed preferential hydrolysis of certain TAG species over others. SM depletion affected the specificity of the enzyme towards PC and TAG species modestly. These results show that SM is a physiological inhibitor of HL activity in lipoproteins and that the specificity of the enzyme towards HDL is at least partly due to its low SM content.

Indexed as

HumansLipaseLipoproteinsPhosphatidylcholinesSphingomyelinsSubstrate SpecificityTriglyceridesLipaseLIPC protein, humanLipoproteinsPhosphatidylcholinesSphingomyelinsTriglyceridesEnzyme inhibitionHepatic lipasePC speciesSphingomyelinSubstrate specificityTAG species

Identifiers

PMID26193433
PMCPMC4561581
OpenAlexW1133495844

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.